Works matching IS 13520504 AND DT 2019 AND VI 26 AND IP 3
Results: 11
Applying core theory and spatial analysis to identify hepatitis C virus infection "core areas" in British Columbia, Canada.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 373, doi. 10.1111/jvh.13043
- By:
- Publication type:
- Article
Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 362, doi. 10.1111/jvh.13041
- By:
- Publication type:
- Article
Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting antiviral therapy without ribavirin.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 407, doi. 10.1111/jvh.13042
- By:
- Publication type:
- Article
Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct‐acting antiviral therapies in the United States.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 350, doi. 10.1111/jvh.13039
- By:
- Publication type:
- Article
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 337, doi. 10.1111/jvh.13038
- By:
- Publication type:
- Article
The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysis.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 329, doi. 10.1111/jvh.13037
- By:
- Publication type:
- Article
Efficacy and safety of antiviral treatment on blocking the mother‐to‐child transmission of hepatitis B virus: A meta‐analysis.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 397, doi. 10.1111/jvh.13036
- By:
- Publication type:
- Article
Characterization of changes in intrahepatic immune cell populations during HCV treatment with sofosbuvir and ribavirin.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 323, doi. 10.1111/jvh.13034
- By:
- Publication type:
- Article
Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real‐world experience of a retrospective study.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 316, doi. 10.1111/jvh.13033
- By:
- Publication type:
- Article
Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 384, doi. 10.1111/jvh.13029
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 313, doi. 10.1111/jvh.12952
- Publication type:
- Article